Pediatric inflammatory bowel disease in mother‒child pairs: clinical risk factors and gut microbiota characteristics.

Cunzheng ZHANG; Ruqiao DUAN; Nini DAI; Yuzhu CHEN; Gaonan LI; Xiao'ang LI; Xiaolin JI; Xuemei ZHONG; Zailing LI; Liping DUAN

Return

Pediatric inflammatory bowel disease in mother‒child pairs: clinical risk factors and gut microbiota characteristics.

Author: Cunzheng ZHANG ¹ ; Ruqiao DUAN ¹ ; Nini DAI ² ; Yuzhu CHEN ¹ ; Gaonan LI ¹ ; Xiao'ang LI ¹ ; Xiaolin JI ¹ ; Xuemei ZHONG ³ ; Zailing LI ⁴ ; Liping DUAN ⁵
Author Information

1. Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China.
2. Department of Pediatrics, Peking University Third Hospital, Beijing 100191, China.
3. Department of Gastroenterology, Children's Hospital Capital Institute of Pediatrics, Beijing 100020, China.
4. Department of Pediatrics, Peking University Third Hospital, Beijing 100191, China. duanlp@bjmu.edu.cn, topbj163@sina.com.
5. Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China. duanlp@bjmu.edu.cn.
Publication Type:Journal Article
Keywords: Gut microbiota; Inflammatory bowel disease (IBD); Mother‒child pair; Risk factor
MeSH: Humans; Gastrointestinal Microbiome; Female; Risk Factors; Case-Control Studies; Male; Child; Inflammatory Bowel Diseases/etiology*; Adult; RNA, Ribosomal, 16S/genetics*; Feces/microbiology*; Mothers; Pregnancy; Child, Preschool
From: Journal of Zhejiang University. Science. B 2025;26(10):995-1014
CountryChina
Language:English
Abstract: OBJECTIVES:The risk factors and role of mother‒child gut microbiota in pediatric inflammatory bowel disease (PIBD) remain unclear. We aimed to explore the clinical risk factors associated with PIBD, analyze the characteristics of gut microbiota of children and their mothers, and examine the correlation of the microbial composition in mother‒child pairs.
METHODS:We conducted a case-control study including children with PIBD and their mothers as the case group, as well as healthy children and their mothers as the control group. Questionnaires were used to collect information such as family illness history and maternal and early-life events. Fecal samples were collected from the children and mothers for microbiota 16S ribosomal RNA (rRNA) sequencing to analyze the composition and its potential association with PIBD.
RESULTS:A total of 54 pairs of cases and 122 pairs of controls were recruited. A family history of autoimmune disease and antibiotic use during pregnancy were associated with an increased risk of PIBD, and a higher education level of the father was associated with a decreased risk of PIBD. Children with PIBD and mothers exhibited different gut microbiota compared to healthy children and mothers. Similarities were observed in the gut microbiota of mothers and children in the same groups. Some bacterial biomarkers of mothers discovered in this study had the power to predict PIBD in their offspring.
CONCLUSIONS:PIBD is influenced by maternal risk factors and has unique gut microbiota characteristics. The mother‒child gut microbiota is closely related, suggesting the transmission and influence of the gut microbiota between mothers and children. This study highlights the potential pathogenesis of PIBD and provides a basis for developing targeted interventions.